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Abstract
The successive treatment of the N,N-disubstituted 4-hydroxy-2-methylbutanamide 2a with LDA and
diphenyl phosphorochloridate (DPPCl) led to the 1-methylcyclopropanecarboxamide 10 in good yield.
This base-catalyzed cyclization offers a new approach to cyclopropanecarboxamides. Under similar
conditions, the N-monosubstituted 4-hydroxy-2-methylbutanamide 2b gave the
3-methylpyrrolidin-2-one 11. The structure of the cyclopropanecarboxamide 10 was established by
X-ray crystallography.
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The successive treatment of the N,N-disubstituted 4-hydroxy-2-methylbutanamide 2a 
with LDA and diphenyl phosphorochloridate (DPPCl) led to the 1-
methylcyclopropanecarboxamide 10 in good yield. This base-catalyzed cyclization offers a 
new approach to cyclopropanecarboxamides. Under similar conditions, the N-
monosubstituted 4-hydroxy-2-methylbutanamide 2b gave the 3-methylpyrrolidin-2-one 11. 
The structure of the cyclopropanecarboxamide 10 was established by X-ray crystallography. 
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Introduction. – In the last four decades it has been demonstrated that 2,2-
disubstituted 2H-azirin-3-amines of type 1 are attractive building blocks for the introduction 
of 2,2-disubstituted glycines into peptides as well as for the synthesis of heterocycles [1]. The 
N-methyl-N-phenyl derivatives are conveniently accessible via successive treatment of 
anilides 2 with lithium diisopropylamide (LDA), diphenyl phosphorochloridate (DPPCl) and 
NaN3 [2] (Scheme 1). It is believed that 1-azidoenamines 3 are intermediates, which 
spontaneously cyclize via elimination of N2 to give 2H-azirines 1. 
 
Scheme 1 
 
Two typical examples for ring enlargement reactions with 1 are shown in Scheme 1. 
The reaction with NH-acidic isothiazol-3(2H)-one 1,1-dioxides 4 leads to 8-membered 1,2,5-
thiadiazocine derivatives 5 via cleavage of the N(1),C(3)-double bond of 1 [3], whereas 
treatment of 1 with BF3.OEt2 and subsequent hydrolysis gives 2-oxindoles (2,3-dihydro-1H-
indol-2-ones) 6 via N(1),C(2) ring opening [4]. In the second example, a 2-allyl-substituted 
azirine 1 (R1 = allyl, R2 = Me) has been used for the preparation of a 3-allyloxindole 6 (R1 = 
allyl, R2 = Me), which was further transformed into (±)-desoxynoreseroline [5]2). This 
example shows that azirines of type 1 with a functionalized side-chain R1 are of high interest 
for the synthesis of more complex heterocycles3). 
                                                 
2) The 3-allyloxindol 6 (R1 = allyl, R2 = Me) [4a] was transformed into 3-(2-hydroxyethyl)-
1,3-dimethyloxindole via ozonolysis and subsequent NaBH4 reduction [6]. Subsequent 
treatment with SOCl2 and NH3 yielded 3-(2-aminoethyl)-1,3-dimethyloxindole, a precursor 
for the cyclization to (±)-desoxynoreseroline. 
3) For the synthesis of 2H-azirin-3-amines with a functionalized side-chain, see also [7]. 
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For this reason, the synthesis of 2H-azirin-3-amines 1 with an OH group in the residue 
R1 was undertaken. These attempts led to unexpected results, which are presented in this 
report. 
 
Results and Discussion. – The desired precursor 2a for the azirine synthesis was 
obtained by the Al3-catalyzed amination of α-methyl-γ-butyrolactone 7 with N-methylaniline 
according to the protocol described in [8] (see also [7a]). The reaction proceeded smoothly 
and the known 2a [7a][8] was obtained in 84% yield as colorless crystals with a m.p. of 78–
78.8°. All attempts to synthesize the 2H-azirin-3-amine 1a (R1 = HOCH2CH2, R2 = Me) 
according to the method described in [2] (see Scheme 1) by using ca. 1.1 equiv. of LDA 
failed, and only the azide 8 was isolated in 48% yield as a yellow oil (Scheme 2). The 
structure determination was based on the analytical data and the IR, 1H- and 13C-NMR data. 
The presence of the azido group was evidenced by the strong IR absorptions at 2096 and 1266 
cm-1 for the asymmetric and symmetric stretching vibration. The base peak in the CI-MS 
appeared at m/z 190 ([M+1]), corresponding with the formula C12H15NO for the product. 
The formation of 8 can easily be explained by the reaction of the alcoholate of 2a with 
DPPCl to give the corresponding alkyl diphenyl phosphate 9 (see, e.g., [9]), followed by an 
SN2-reaction by the azide ion. 
 
Scheme 2 
 
In the next experiment, 2a was treated with ca. 2.2 equiv. of LDA, followed by ca. 1.1 
equiv. of diphenyl phosphorchloridate (DPPCl). Surprisingly, a new, rather unpolar product 
was formed (TLC), which, after chromatographic workup, was obtained as a colorless, 
crystalline material. On the basis of the spectroscopic and analytical data, the structure was 
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determined as 1,N-dimethyl-N-phenylcyclopropane carboxamide 10 (Scheme 2). Finally, this 
structure was established by X-ray crystallography (Figure). 
 
Figure. ORTEP plot [10] of the molecular structure of 10 (50% probability ellipsoids, 
arbitrary numbering of the atoms) 
 
A likely intermediate in the formation of 10 is the anion of 9, which undergoes the 
cyclization to give the cyclopropane by elimination of diphenylphosphate (cf. [11]). 
The analogous reaction of the N-monosubstituted amide 2b, which had been prepared 
by the reaction of 7 with 4-methoxyaniline, with ca. 3.3 equiv. of LDA gave, after 
chromatographic workup, a product with a base peak in the CI-MS at m/z 206 ([M+1]+), 
corresponding with a molecular formula of C12H15NO2, i.e. the product of the dehydration. 
The 1H- and 13C-NMR data clearly indicated that the product was not the expected 
cyclopropane carboxamide: the NMR spectra showed signals of two different CH2 groups 
(e.g. 13C-NMR: 46.8 and 27.0 ppm) and of a CH group (37.9 ppm). Whereas the IR 
absorption at 1685 cm–1 was in agreement with the structure of lactame 11 [12] as well as 
with the iminolactone 11’ [13], the NMR data clearly indicate that 11 has been formed 
(Scheme 3). The CH2 signals at 46.8 (13C) and 3.77–3.72 (1H) ppm are characteristic for the 
CH2N group [14], whereas the CH2O signals of 11’ would be expected at ca. 62 and 4.2 ppm, 
respectively [15][16]. The formation of 11 may be rationalized by the cyclization of 
intermediate 12. Although ring closure via nucleophilic attack of the O- or the N-atom of the 
amide group is possible, it has been shown that in the case of 4-bromobutyranilide under very 
basic conditions, i.e. in the cyclization of the corresponding anion, the formation of the lactam 
is strongly preferred [17]. 
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Scheme 3 
 
Finally, the transformations of the OH group of 2a into esters 13 and urethanes 14 
wese achieved via the reactions with acid chlorides and isocyanates, respectively, under 
standard conditions (Scheme 4). 
 
Scheme 4 
 
Conclusions. – The reaction of the N,N-disubstitued 4-hydroxybutanamide 2a with 
two equiv. of LDA and DPPCl leads to the cyclopropane carboxamide 10, whereas the 
analogous N-monosubstituted amide 2b under similar conditions yields the lactam 11. The 
formation of 10 via the base-catalyzed cyclization of 2a offers a new access to the important 
class of cyclopropane carboxamides4), which are known as partial structures of 
physiologically active compounds (e.g., DPP-IV inhibitors [19a], melanocortin receptor 
agonists [19b], antidepressants [19c], HCV NS5B inhibitors [19d][19e], etc.). The described 
results show that for the attempted synthesis of a 2H-azirin-3-amine 1 with an OH-group in 
R1, a starting material 2 with suitably protected OH group should be used. 
 
 
We thank the analytical units of our institute for spectra and analyses. Financial 
support of the work by the Swiss National Science Foundation and F. Hoffmann-La Roche 
AG, Basel, is gratefully acknowledged.  
 
 
                                                 
4) For recent syntheses of cyclopropane carboxamides, see [18]. 
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Experimental Part 
 
1. General. Solvents were purified by standard procedures. TLC: aluminium sheets, 
silica gel 60 F254 (Merck). Prep. TLC: glass plates, silica gel 60 F254 (2 mm; Merck). Column 
chromatography (CC): silica gel C-560 (0.04–0.063 mm; Uetikon-Chemie). Medium pressure 
liquid chromatography (MPLC): LiChroprep Si 60, 15–25 μm (Merck); column: Kron-Lab 
4/98-Pro, 480 × 30 mm or Labomatic, 380 × 20 mm. M.p.: Mettler-FP-5 or Büchi 510 
apparatus; uncorrected.  IR Spectra: Perkin-Elmer-781 or Perkin-Elmer-1600-FT-IR 
spectrophotometer; in KBr unless otherwise stated. 1H- and 13C-NMR Spectra: Bruker-ARX-
300 instrument (300 and 75.5 MHz, resp.), in CDCl3; multiplicity of C-atoms from DEPT 
spectra. MS: Finnigan MAT-90, Finnigan SSQ-700 (CI with NH3), or Finnigan TSQ-700 
instrument (ESI). Elemental analyses were performed by the Mikroanalytisches Laboratorium 
des Organisch-chemischen Instituts der Universität Zürich (Elementar Vario EL instrument).  
2. Starting Materials. The preparation of 4-hydroxy-2,N-dimethyl-N-
phenylbutanamide (2a) was carried out according to [8] and has been previously described in 
[7a]. All other reagents were commercially available. 
3. Reactions with 4-Hydroxy-2,N-dimethyl-N-phenylbutanamide (2a). 3.1. 4-Azido-
2,N-dimethyl-N-phenylbutanamide (8). To a stirred soln. of diisopropylamine (0.47 ml, 3.32 
mmol) in THF (10 ml) at –20°, BuLi (2M soln. in pentane, 1.60 ml, 3.20 mmol) was added 
under Ar, and the mixture was allowed to warm to 0°. A soln. of 2a (600 mg, 2.89 mmol) in 
THF (5 ml) was added dropwise, and the mixture was stirred at 0° for 1 h. Then, diphenyl 
phorphorochloridate (DPPCl, 0.62 ml, 2.98 mmol) was added dropwise. After 30 min, the ice 
bath was removed and the mixture stirred at r.t. for 24 h. The formed precipitate was filtered 
off under Ar, the THF soln. was dropped into a suspension of NaN3 (0.565 mg, 8.69 mmol) in 
dry DMF (1.5 ml), and the mixture was stirred at r.t. for 4 d. Then, Et2O was added and the 
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mixture filtered over celite pad, the solvent evaporated, and the residue dissolved in Et2O. The 
soln. was washed with 5% aq. NaHCO3 (2×), the aq. layer was washed with Et2O, the 
combined org. layers were dried (MgSO4), the solvent was evaporated under reduced 
pressure, and the crude product was purified by bulb-to-bulb destillation and CC 
(Et2O/hexane 2:5). Yield: 322 mg (48%) of 8. Yellow oil. IR (film): 3061w, 2971m, 2934m, 
2875m, 2096s, 1654s, 1595s, 1496s, 1462s, 1426s, 1390s, 1328m, 1266s, 1173w, 1116s, 
1074m, 1037m, 1001w, 916w, 775m, 750w, 701s. 1H-NMR: 7.50–7.36, 7.23–7.19 (2m, 5 
arom. H); 3.32–3.14 (m, CH2N3); 3.28 (s, MeN), 2.64–2.49 (m, CH); 2.09–1.93, 1.60–1.47 
(2m, CH2); 1.05 (d, J = 6.8, Me). 13C-NMR: 175.6 (s, CO); 143.7 (s, 1 arom. C); 129.7, 127.9, 
127.2 (3d, 5 arom. CH); 49.3, 32.9 (2t, 2 CH2); 37.4 (q, MeN); 33.8 (d, CH); 18.0 (q, Me). CI-
MS: 234 (14), 233 (100, [M+1]+), 205 (13), 190 (11), 107 (9). 
3.2. 1,N-Dimethyl-N-phenylcyclopropanecarboxamide (10). To a stirred soln. of 
diisopropylamine (0.94 ml, 6.65 mmol) in THF (10 ml) at –20°, BuLi (2M soln. in pentane, 
3.19 ml, 6.38 mmol) was added under Ar, and the mixture was allowed to warm to 0°. A soln. 
of 2a (600 mg, 2.89 mmol) in THF (5 ml) was added dropwise, and the mixture was stirred at 
0° for 1 h. Then, DPPCl (1.23 ml, 5.96 mmol) was added dropwise. After 30 min, the ice bath 
was removed and the mixture stirred at r.t. for 24 h. The formed precipitate was filtered off 
under Ar, the solvent was evaporated, and Et2O was added. The mixture was filtered over 
celite pad, the solvent was evaporated, and the residue dissolved in Et2O. The soln. was 
washed with 5% aq. NaHCO3 (2×), the aq. layer was washed with Et2O, the combined org. 
layers were dried (MgSO4), the solvent was evaporated under reduced pressure, and the crude 
product was purified by CC (Et2O/hexane 1:5). Yield: 412 mg (75%) of 10. Crystallization 
from hexane gave colorless prisms. M.p. 77.5–78.5°. IR: 3089w, 3046w, 2969m, 2951m, 
2924m,  2867w,  1637s,  1594s,  1496s, 1469m, 1434m, 1413s, 1383s, 1370s, 1311m, 1284w, 
1246s, 1158w, 1118s, 1076w,  948w, 910w, 859w, 811w,  198w, 779m, 750m, 706s. 1H-NMR: 
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7.45–7.35, 7.31–7.20 (2m, 5 arom. H); 3.29 (s, MeN); 1.12–1.05, 0.44–0.37 (2m, 2 CH2); 0.92 
(s, Me). 13C-NMR: 174.5 (s, CO); 144.5 (s, 1 arom. C); 129.1, 127.1, 126.8 (3d, 5 arom. CH); 
39.0 (q, MeN); 21.9 (q, Me); 20.8 (s, C(1)); 15.5 (t, CH2). CI-MS: 191 (12), 190 (100, 
[M+1]+). Anal. calc. for C12H15NO (189.25): C 75.16, H 7.99, N 7.40; found: C 76.14, H 7.85, 
N 7.44. 
Crystals suitable for the X-ray crystal-structure determination were grown from 
hexane by slow evaporation of the solvent. 
4. Reaction with 4-Hydroxy-N-(4-methoxyphenyl)-2-methylbutanamide (2b). 4.1. 
Preparation of 2b. In analogy to [8], a soln. of 4-methoxyaniline (1.54 g, 12.51 mmol) in 1,2-
dichloroethane (4.5 ml) was added to a stirred suspension of AlCl3 (0.87 g, 6.50 mmol) in 1,2-
dichloroethane (2.5 ml) at 15–25°. Then, α-methyl-γ-butyrolactone (7, 0.5 ml, 5.28 mmol) 
was added and the mixture was stirred at r.t. for 4 h. After quenching with a mixture of ice 
and H2O (5 ml), the mixture was stirred for an additional 0.5 h, the resulting suspension was 
filtered over celite, and the org. phase was separated. The aq. phase was extracted with 
CH2Cl2, and the combined org. phase was washed with H2O and brine, and dried (Na2SO4). 
Evaporation of the solvent and CC (CH2Cl2/MeOH 100:1) yielded 5.75 mg (52%) of 2b.  Pale 
rosa powder. M.p. 95.5°. IR: 3443m, 3283s, 3193m, 3133m, 3071w, 2974m, 2953m, 2934m, 
2837m, 1652s, 1603s, 1549s, 1514s, 1459m, 1444m, 1415m, 1380m, 1348m, 1298s, 1239s, 
1185m, 1170m, 1134w, 1098m, 1053s, 1000m, 944w, 828s, 807w, 762w, 716m. 1H-NMR: 
7.88 (br. s, NH); 7.37, 6.79 (AA’BB’, 4 arom. H); 3.75 (s, MeO); 3.71–3.64 (m, CH2O); 2.87 
(br. s, OH); 2.68–2.54 (m, CH); 1.97–1.84, 1.76–1.62 (2m, CH2); 1.22 (d, J = 6.9, Me). 13C-
NMR: 175.0 (s, CO); 156.3, 130.9 (2s, 2 arom. C); 121.9, 114.0 (2d, 4 arom. CH); 60.1, 36.5 
(2t, 2 CH2); 55.4 (q, MeO); 38.5 (d, CH); 17.6 (q, Me). CI-MS: 225 (12), 224 (100, [M+1]+), 
207 (9), 206 (77). Anal. calc. for C12H17NO3 (223.27): C 64.55, H 7.67, N 6.27; found: C 
64.53, H 7.85, N 6.15. 
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4.2. 1-(4-Methoxyphenyl)-3-methylpyrrolidin-2-one (11). To a stirred soln. of 
diisopropylamine (0.66 ml, 4.66 mmol) in THF (20 ml) at –20°, BuLi (2M soln. in pentane, 
2.20 ml, 4.44 mmol) was added under Ar, and the mixture was allowed to warm to 0°. A soln. 
of 2b (300 mg, 1.34 mmol) in THF (5 ml) was added dropwise, and the mixture was stirred at 
0° for 1 h. Then, DPPCl (0.86 ml, 4.13 mmol) was added dropwise. After 30 min, the ice bath 
was removed and the mixture stirred at r.t. for 24 h. The mixture was worked up as described 
in chapter 3.2, and the crude product was purified by CC (Et2O/hexane 1:2). Yield: 240 mg 
(87%) of 11. Colorless crystals. M.p. 83.1–84.8°. IR: 2952m, 2836w, 1879w, 1685s, 1515s, 
1482m, 1442m, 1397s, 1324m, 1290m, 1252s, 1226s, 1180m, 1121m, 1098m, 1050m, 1030s, 
918w, 884w, 830s, 790w, 720w, 704w. 1H-NMR: 7.53, 690 (AA’BB’, 4 arom. H); 3.81 (s, 
MeO); 3.77–3.72 (m, CH2O); 2.73–2.59 (m, CH); 2.43–2.30, 1.83–1.70 (2m, CH2); 1.30 (d, J 
= 4.7, Me). 13C-NMR: 176.2 (s, O–C=N); 156.3, 132.9 (2s, 2 arom. C); 121.4, 113.9 (2d, 4 
arom. CH); 55.4 (q, MeO); 46.8, 27.0 (2t, 2 CH2); 37.9 (d, CH); 16.2 (q, Me). CI-MS: 411 (9, 
[2M+1]+), 223 (8, [M+NH4]+), 207 (13), 206 (100, [M+1]+). Anal. calc. for C12H15NO2 
(205.25): C 70.22, H 7.37, N 6.82; found: C 70.10, H 7.65, N 6.92. 
5. Reaction of 2a with Acid Chlorides. - General Procedure 1 (GP 1). To a soln. of 2a 
in dioxane, the corresponding acid chloride and Et3N were added, and the mixture was heated 
to reflux for 2 h. The solvent was evaporated and CH2Cl2 was added, the org. phase was 
washed with 10% aq. HCl, sat. aq. NaHCO3, and brine and was dried (Na2SO4). After 
filtration, the solvent was evaporated under reduced pressure, and pure product was obtained 
after CC. 
5.1. 3-Methyl-4-(N-methyl-N-phenylamino)-4-oxobutyl Acetate (13a). According to 
GP 1, 2a (100 mg, 0.48 mmol), dioxane (5 ml), acetyl chloride (0.04 ml, 0.56 mmol), and 
Et3N (0.05 ml, 0.36 mmol). Yield: 108 mg (90%) of 13a. Colorless, viscous oil, which 
solidified on cooling. IR: 3062w, 3039w, 2970m, 2937m, 2878m, 1745s, 1650s, 1596s, 1497s, 
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1463m, 1429s, 1391s, 1365m, 1329m, 1244s, 1118s, 1074m, 1039s, 776s, 703s. 1H-NMR: 
7.38–7.22, 7.13–7.07 (2m, 5 arom. H); 3.89 (t, J = 6.2, CH2O); 3.18 (s, MeN); 2.53–2.40, 
2.02–1.89, 1.55–1.42 (3m, CH, CH2); 1.83 (s, MeCO); 0.98 (d, J = 6.8, Me). 13C-NMR: 174.8 
(s, O–C=O); 169.8 (s, CO); 143.0 (s, 1 arom. C); 128.8, 126.8, 126.4 (3d, 5 arom. CH); 61.5 
(t, CH2O) 36.4 (q, MeN); 32.3 (d, CH); 32.1 (t, CH2); 19.8 (q, MeCO); 17.1 (q, Me). CI-MS: 
516 (54, [2M+NH4]+), 499 (21, [2M+1]+), 267 (33, [M+NH4]+), 251 (15), 250 (100, [M+1]+), 
249 (13, M+), 190 (24). 
5.2. 3-Methyl-4-(N-methyl-N-phenylamino)-4-oxobutyl Dichloroacetate (13b). 
According to GP 1, 2a (150 mg, 0.72 mmol), dioxane (10 ml), dichloroacetyl chloride (0.11 
ml, 1.14 mmol), and Et3N (0.1 ml, 0.72 mmol). Yield: 200 mg (87%) of 13b. Yellowish, 
viscous oil. 1H-NMR: 7.39–7.25, 7.16–7.09 (2m, 5 arom. H); 5.73 (s, CHCl2); 4.20–4.03 (m, 
CH2O); 3.19 (s, MeN); 2.58–2.45, 2.11–1.98, 1.64–1.50 (3m, CH, CH2); 0.98 (d, J = 6.8, Me). 
13C-NMR: 175.2 (s, O–C=O); 164.2 (s, CO); 143.7 (s, 1 arom. C); 129.8, 127.8, 127.2 (3d, 5 
arom. CH); 65.6 (t, CH2O) 64.1 (s, CHCl2); 37.4 (q, MeN); 33.0 (d, CH); 32.5 (t, CH2); 18.0 
(q, Me). CI-MS: 335 (17, [M+NH4]+), 318 (100, [M+1]+), 284 (19), 228 (21), 226 (64). Anal. 
calc. for C14H17Cl2NO3 (318.20): C 52.84, H 5.39, N 4.40, Cl 22.28; found: C 53.10, H 5.32, 
N 4.42, Cl 21.94. 
5.3. 3-Methyl-4-(N-methyl-N-phenylamino)-4-oxobutyl Cyclopropanecarboxylate 
(13c). According to GP 1, 2a (100 mg, 0.48 mmol), dioxane (10 ml), cyclopropanecarbonyl 
chloride (0.04 ml, 0.44 mmol), and Et3N (0.07 ml, 0.50 mmol). Yield: 127 mg (95%) of 13c. 
Pale yellow oil. IR (film): 3061w, 3014w, 2968m, 2935m, 1719s, 1654s, 1595s, 1496s, 1454s, 
1390s, 1366s, 1328m, 1270s, 1199s, 1178s, 1117s, 1074m, 1034m, 1000w, 938w, 913w, 
853w, 824w, 775m, 747w, 702s. 1H-NMR: 7.38–7.21, 7.11–7.07 (2m, 5 arom. H); 3.88 (t, J = 
6.2, CH2O); 3.17 (s, MeN); 2.53–2.40, 2.02–1.90, 1.54–1.42, 1.41–1.32 (4m, 2 CH, CH2); 
0.98 (d, J = 6.8, Me); 0.89–0.79, 0.78–0.69 (2m, 2 CH2). 13C-NMR: 175.7 (s, O–C=O); 174.5 
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(s, CO); 143.9 (s, 1 arom. C); 129.6, 127.7, 127.2 (3d, 5 arom. CH); 62.5 (t, CH2O); 37.3 (q, 
MeN); 33.2 (d, CH); 33.1 (t, CH2); 18.0 (q, MeCO); 12.7 (d, CH); 8.2, 8.1 (2t, 2 CH2). CI-
MS: 277 (16), 276 (100, [M+1]+), 190 (11). 
5.4. 3-Methyl-4-(N-methyl-N-phenylamino)-4-oxobutyl Benzoate (13d). According to 
GP 1, 2a (300 mg, 1.45 mmol), dioxane (20 ml), benzoyl chloride (0.17 ml, 1.45 mmol), and 
Et3N (0.2 ml, 1.43 mmol). Yield: 370 mg (82%) of 13d. Colorless, viscous oil, which 
solidified in h.v. IR (film): 3062w, 2970m, 1716s, 1654s, 1596s, 1496s, 1452s, 1428m, 1391s, 
1315m, 1274s, 1176m, 1117s, 1071m, 1028m, 1001w, 950w, 846w, 775m, 749w, 713s. 1H-
NMR: 7.85–7.80, 7.50–7.45, 7.35–7.30, 7.10–7.00 (4m, 10 arom. H); 4.18 (br.s, CH2O); 3.18 
(br.s, MeN); 2.65–2.60, 2.15–2.05, 1.70–1.60 (3m, CH, CH2); 1.04 (br.s, Me). 13C-NMR: 
175.6 (s, O–C=O); 166.2 (s, CO); 143.8, 135.5 (2s, 2 arom. C); 132.7, 129.6, 129.4, 128.1, 
127.5, 127.1 (6d, 10 arom. CH); 62.9 (t, CH2O) 37.2 (q, MeN); 33.3 (d, CH); 33.1 (t, CH2); 
18.1 (q, Me). CI-MS: 329 (7, [M+NH4]+), 313 (18), 312 (100, [M+1]+), 190 (5), 178 (19). 
Anal. calc. for C19H21NO3 (311.37): C 73.29, H 6.80, N 4.50; found: C 73.04, H 6.69, N 4.50. 
5.5. 3-Methyl-4-(N-methyl-N-phenylamino)-4-oxobutyl 4-Nitrobenzoate (13e). 
According to GP 1, 2a (150 mg, 0.72 mmol), dioxane (10 ml), 4-nitrobenzoyl chloride (134 
mg, 0.72 mmol), and Et3N (0.1 ml, 0.72 mmol). Yield: 128 mg (50%) of 13e. Pale yellow 
solid. M.p. 98.7°. IR: 3115w, 2970w, 2934w, 1724s, 1651s, 1610m, 1594m, 1527s, 1516s, 
1496m, 1458m, 1427m, 1394m, 1350m, 1324m, 1280s, 1154w, 1122s, 1106m, 1080w, 1021m, 
948w, 874w, 848w, 819w, 777w, 719s, 705m. 1H-NMR: 8.17, 7.97 (AA’BB’, 4 arom. H); 
7.27–7.13, 7.10–7.04 (2m, 5 arom. H); 4.22 (t-like, CH2O); 3.18 (s, MeN); 2.68–2.53, 2.25–
2.08, 1.73–1.61 (3m, CH, CH2); 1.05 (d, J = 6.8, Me). 13C-NMR: 175.5 (s, O–C=O); 164.3 (s, 
CO); 150.4, 143.9, 135.4 (3s, 3 arom. C); 130.6, 129.7, 127.7, 127.1, 123.3 (5d, 9 arom. CH); 
64.0 (t, CH2O) 37.4 (q, MeN); 33.4 (d, CH); 32.9 (t, CH2); 18.1 (q, Me). CI-MS: 358 (19), 
357 (100, [M+1]+), 328 (7), 327 (37), 240 (17), 223 (43). Anal. calc. for C19H20N2O5 (356.38): 
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C 64.04, H 5.66, N 7.86; found: C 63.88, H 5.76, N 7.93. 
6. Reaction of 2a with Isocyanates. - General Procedure 2 (GP 2). To a soln. of 2a in 
dry benzene, the corresponding isocyanate was added, and the mixture was heated to reflux 
for 4 h. The solvent was evaporated and the crude product was purified by CC. 
6.1. 3-(N-Methyl-N-phenylcarbamoyl)butyl tert-Butylcarbamate (14a). According to 
GP 2, 2a (100 mg, 0.48 mmol), benzene (10 ml), tert-butylisocyanate (0.06 ml, 0.51 mmol). 
Yield: 100 mg (68%) of 14a. Colorless, viscous oil. IR (CHCl3): 3441w, 3007m, 2970m, 
2874w, 1719s, 1641s, 1596m, 1508s, 1498s, 1457m, 1431m, 1092m, 1038w, 1001w, 921w, 
839w. 1H-NMR: 7.69–7.54, 7.44–7.38 (2m, 5 arom. H); 4.70 (br.s, NH); 4.22–4.05 (m, 
CH2O); 3.49 (s, MeN); 2.82–2.69, 2.32–2.17, 1.85–1.70 (3m, CH, CH2); 1.52 (s, 3 Me); 1.29 
(d, J = 6.8, Me). 13C-NMR: 175.8 (s, CO); 154.7 (s, O–C(O)–N); 144.0 (s, 1 arom. C); 129.6, 
127.6, 127.3 (3d, 5 arom. CH); 62.1 (t, CH2O); 50.0 (s, Me3C); 37.3 (q, MeN); 33.4 (t, CH2); 
33.3 (d, CH); 28.8 (q, Me3C); 18.0 (q, Me). ESI-MS: 329 (27, [M+Na]+), 307 (85, [M+1]+), 
208 (47), 190 (100). 
6.2. 3-(N-Methyl-N-phenylcarbamoyl)butyl Cyclohexylcarbamate (14b). According to 
GP 2, 2a (150 mg, 0.72 mmol), benzene (20 ml), cyclohexylisocyanate (0.095 ml, 0.75 
mmol). Yield: 175 mg (73%) of 14b. Colorless, viscous oil. IR (CHCl3): 3445w, 3023s, 
2977s, 2896m, 1709s, 1642m, 1590m, 1521s, 1477m, 1424s, 1047s, 929s, 877m, 850s. 1H-
NMR: 7.48–7.32, 7.25–7.17 (2m, 5 arom. H); 4.49 (br.d, NH); 4.03–3.88 (m, CH2O); 3.27 (s, 
MeN); 2.62–2.45 (m, CH); 2.08–1.10 (m, CH2, 11 H of cyclo-hex); 1.05 (d, J = 6.8, Me). 13C-
NMR: 175.8 (s, CO); 155.5 (s, O–C(O)–N); 144.0 (s, 1 arom. C); 129.6, 127.6, 127.3 (3d, 5 
arom. CH); 62.6 (t, CH2O); 49.6 (d, CH of cyclo-hex); 37.3 (q, MeN); 33.4 (t, CH2); 33.2 (d, 
CH); 33.3, 25.3, 24.6 (3t, 5 CH2 of cyclo-hex); 18.0 (q, Me). ESI-MS: 371 (9, [M+K]+), 356 
(13), 355 (100, [M+Na]+), 333 (10, [M+1]+), 190 (11), 156 (8). 
6.3. 3-(N-Methyl-N-phenylcarbamoyl)butyl Phenylcarbamate (14c). According to GP 
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2, 2a (150 mg, 0.72 mmol), benzene (20 ml), phenylisocyanate (0.08 ml, 0.72 mmol). Yield: 
161 mg (68%) of 14c. Colorless, viscous oil. IR (CHCl3): 3436w, 3023s, 2977s, 2896m, 
1732s, 1642m, 1597m, 1521s, 1477m, 1424s, 1047s, 929s, 877m, 850s. 1H-NMR: 7.52–7.30, 
7.27–7.20, 7.17–7.08 (3m, 10 arom. H); 4.70 (br.s, NH); 4.20–4.02 (m, CH2O); 3.30 (s, 
MeN); 2.70–2.56, 2.22–2.07, 1.72–1.59 (3m, CH, CH2); 1.13 (d, J = 6.8, Me). 13C-NMR: 
175.8 (s, CO); 153.4 (s, O–C(O)–N); 143.8, 138.1 (2s, 2 arom. C); 129.7, 128.8, 127.7, 127.2, 
123.1, 118.4 (6d, 10 arom. CH); 63.1 (t, CH2O); 37.3 (q, MeN); 33.4 (t, CH2); 33.2 (d, CH); 
18.1 (q, Me). CI-MS: 328 (20), 327 (100, [M+1]+), 208 (11), 191 (10), 190 (81). 
7. X-Ray Crystal-Structure Determination of 10 (Table and Figure)5). All 
measurements, with the exception of those of 23, were performed on a Rigaku AFC5R 
diffractometer using graphite-monochromated MoKα radiation (λ 0.71069 Å) and a 12kW 
rotating anode generator. The data collection and refinement parameters are given in the 
Table, and a view of the molecule is shown in the Figures. The intensities were corrected for 
Lorentz and polarization effects, not for absorption. The structure was solved by direct 
methods using SHELXS97 [20], which revealed the positions of all non-H-atoms. The non-H-
atoms were refined anisotropically. All of the H-atoms were fixed in geometrically calculated 
positions (d(C–H) = 0.95 Å) and each was assigned a fixed isotropic displacement parameter 
with a value equal to 1.2Ueq of its parent C-atom.  Refinement of the structure was carried out 
on F using full-matrix least-squares procedures, which minimized the function Σw(⏐Fo⏐– 
⏐Fc⏐)2. A correction for secondary extinction was applied. Neutral atom scattering factors for 
non-H-atoms were taken from [21a], and the scattering factors for H-atoms were taken from 
[22]. Anomalous dispersion effects were included in Fc [23]; the values for f ' and f " were 
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those of [21b]. The values of the mass attenuation coefficients are those of [21c]. All 
calculations were performed using the teXsan [24] crystallographic software package. 
 
Table 2. Crystallographic Data for Compound 10 
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Legends 
 
Fig. 1. ORTEP Plot [10] of the molecular structure of 10 (50% probability ellipsoids, 
arbitrary numbering of the atoms) 
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Table.  Crystallographic Data for Compound 10 
__________________________________________________________________________________ 
  
 10  
__________________________________________________________________________________ 
 
Crystallized from hexane  
Empirical formula C12H15NO  
Formula weight 189.26  
Crystal color, habit colorless, prism  
Crystal dimensions [mm] 0.28 × 0.48 × 0.48  
Temperature [K] 173(1)  
Crystal system orthorhombic  
Space group Pcab  
Z 8  
Reflections for cell determination 25  
2θrange for cell determination [°] 34 – 40  
Unit cell parameters a [Å] 20.820(2)  
 b [Å] 14.230(3)  
 c [Å] 7.055(2)  
 V [Å3] 2090.2(6)  
Dx [g cm–1] 1.203  
μ(MoKα) [mm–1] 0.0763   
Scan type ω/2θ 
2θ(max) [°] 55  
Total reflections measured 3338  
Symmetry independent reflections 2391  
Reflections used [I > 2σ(I)] 1671  
Parameters refined 128  
Final  R 0.0445   
 wR 0.0403  
Weights: p in w = [σ 2(Fo) + (pFo)2]–1 0.01  
Goodness of fit 1.879  
Secondary extinction coefficient 2.0(1) × 10–6  
Final Δmax/σ 0.0003  
Δρ (max; min) [e Å–3] 0.24; –0.19  
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